Richard Markus is Chief Medical Officer at Arcus Biosciences, Inc. (RCUS). They have made 1 open-market trade across 1 company since 2025, most recently 2026-01-23.
CIK 0002056093
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RCUS | 89,647 | $2.0M |
Shares reported on the most recent Form 4, priced at the 2026-01-26 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RCUS | SELL | 2025-12-16 | 2025-12-18 | $22.01 | $420K | +8.4% | -0.1% | +1.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.